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INTRODUCTION 
The term solid dispersion refers to a group of solid 
products consisting of at least two different components, 
generally a hydrophilic matrix and a hydrophobic drug. 
The matrix can be either crystalline or amorphous. The 
drug can be dispersed molecularly, in amorphous particles 
(clusters) or in crystalline particles 1. 
Enhancement of bioavailability of poorly soluble drug has 
become draustic need and challenging aspects for the drug 
development phase 2. For the better absorption of the drug 
it is quite necessary that drug must be soluble and 
permeable which decides the bioavailability of the drug. 
So the formulation of poorly soluble drug for the drug 
delivery has becoming challenging to the research and 
development sectors and work is going through on this.  
So in this case the major approach is the formulation 
approach which is quite simple and increases the solubility 
of the poorly soluble drug by the solid dispersion 
technique. This method, which was later, termed solid 
dispersion which involved the formation of eutectic 
mixture of drugs with water‐soluble carriers by the melting 
of their physical mixtures. 
On the basis generation solid dispersion broadly classified 
into 3 - 
1. First generation solid dispersions- include 
crystalline carriers such as urea 4, 5 and sugars 6.  
2. Second generation solid dispersions- includes 
polymeric carriers which are purely synthetic like 
Povidone (PVP)[7], Polyethylene glycol (PEG) 8, 
polymethylacrylates 9, natural like cellulose 
derivatives, such as hydroxypropylmethylcellulose 
(HPMC)10  ethyl cellulose11 or hydroxypropylcellulose 
or starch derivates, like cyclodextrins[12]. 
3. Third generation solid dispersions- includes blends 
of surfactant and polymers like inulin, inutec SP1, 
compritol 888 ATO13, mixture of PEG and 
polysorbate 80, HPMC was also associated with 
poloxamer and polyoxyethylene hydrogenated castor 
oil to prepare an amorphous  
felodipine solid dispersion.  
MATERIALS 
Paracetamol (PCM) was gifted by Simpex Laboratories 
Kotdwar, India. PEG 4000, buffers was purchased from 
CDH, and all other chemicals used were of analytical 
grade. 
METHODS 
Preparation of physical mixture 
The physical mixture of PCM and PEG 4000 was 
accurately taken in a mortar and triturated smoothly with 
the help of pestle so that mixing makes uniformly, drug 
and carrier mix with each other and distributed equally in 
both the phases. The resulting mixture formed was passed 
through the sieve no.80. The mixture was placed in a 
desiccator to carry the further characterization of prepared 
mixture. 
Preparation of solid dispersion of PCM containing 
PEG 4000 as a carrier 
Firstly the carrier PEG 4000 was melted in a china dish 
over a water bath at temperature 55 0C, then the accurately 
amount of a PCM was incorporated in a molten carrier and 
with the help of glass rod, solid solution formed was 
properly mixed so that uniform mixing takes place. After 
that transfer the china dish over an ice bath and solidify the 
molten mixture, put this system into a desiccator fitted 
with  vaccum remove the moisture from it, passed with the 
sieve and when use transfer in a capsule and evaluation 
was performed. 
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Table 1: Formulation composition for PCM solid 
dispersion containing PEG 4000 as a carrier 
Formulation Code Carrier (PEG 4000) PCM 
RD - 500 mg 
F1* 100 mg 500 mg 
F1 100 mg 500 mg 
F2 200 mg 500 mg 
F3 300 mg 500 mg 
F4 400 mg 500 mg 
 
Characterization of PCM solid dispersions 
Saturation solubility studies of prepared solid 
dispersions 
The excess amount of solid dispersions (physical mixtures 
and prepared dispersion) was added to the 10 ml 
volumetric flask which contains distilled water and 
subjected to kept for maintaining 37 0 C for 26 hours. Then 
the flask were removed and suitable amount of aliquots 
was taken and filtered by using whattmann filter paper and 
diluted by using distilled  water and it is compare with the 
pure drug for solubility profile comparison. 
Appearance of Paracetamol solid dispersion 
By the help of projection microscope at magnification 10 x 
and 40 x the prepared PCM dispersion were analyzed to 
study the phase transformation between the states. 
Drug content analysis 
Preparation equivalent to 100 mg was accurately weighed 
and transferred to 100 ml volumetric flask and mixed in 
100 ml phosphate buffer having pH 5.8., suitable aliquots 
were withdrawn and diluted to appropriate dilution and 
drug content was established using calibration curve of 
PCM at max 243 nm. The drug content was estimated. 
In - vitro release profile characteristics 
In-vitro release of PCM from the solid solution were 
evaluated with a USP XXXI dissolution apparatus type II 
(paddle type, Electrolab, Mumbai, India) at 50 rpm in 
900ml phosphate buffer (pH 5.8) at 37±0.50C. At 
predetermined intervals, a 1ml aliquot was withdrawn and 
replenished with an equal volume of fresh dissolution 
medium. The withdrawn samples were analyzed 
spectrophotometrically at 243nm PCM solid dispersion 
formulations. 
 Kinetics of drug release  
The results of in vitro release profiles obtained for all the 
formulations were fitted into four models of data treatment 
as follows:  
1. Cumulative percent drug released versus time (zero-
order kinetic model).  
2. Log cumulative percent drug remaining versus time 
(first-order kinetic model).  
3. Cumulative percent drug released versus square root of 
time (Higuchi’s model).  
4. Log cumulative percent drug released versus log time 
(Korsemeyer-Peppas equation).  
Stability studies 
The stability studies of selected formulation was carried 
out at the room temperature in a hermitically sealed 
ampoules for 6 months to observe any change in physical 
characteristics, drug content and whether any drug release 
profile alters or not while storage. 
RESULTS AND DISCUSSION 
Callibration curve of Paracetamol in 5.8 pH phosphate 
buffer 
 
Figure 1: Callibration curve of Paracetamol in 5.8 pH 
phosphate buffer at 243 nm 
Saturation solubility studies of prepared solid 
dispersions 
The solubility profile of solid dispersion, physical mixture 
and pure drug was found to be and depicted in the 
following table 2. 
Table 2 Solubility study table in different ratio of carrier 
Formulation Code Method Carrier Solubility in Water mg/ml 
((± S.D, n=3) 
RD - PEG 4000 0.079 ± 0.002 
F1* Trituration PEG 4000 0.102 ± 0.016 
F1 Melting PEG 4000 0.204 ± 0.015 
F2 Melting PEG 4000 0.219 ± 0.023 
F3 Melting PEG 4000 0.245 ± 0.014 
F4 Melting PEG 4000 0.253 ± 0.018 
 
Paracetamol is purely water insoluble drug and its 
solubility at room temperature in pure distilled water was 
estimated 0.079 mg/ml. But the dispersion of PCM with 
PEG 4000 proves a better solubility profile and increases 
the solubility of PCM with as the carrier proportion 
increases. In formulation F1* there is marked increase of 
solubility of PCM with physical mixture of PEG 4000 by 
trituration method, because there is less intimate between 
the drug and carrier so this not so affect the solubility of 
PCM in  physical mixture (F1*). 
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In the another formulations (F1 to F4), the dispersion 
prepared by the melting solidification technique so in this 
there is may be inherent transitions takes place between the 
drug and carrier in manner of hydration, increase in 
wettability phenomenon and possible complex formation 
with the carriers which leads to increase in the solubility 
ranging from 0.204mg/ml to 0.253 mg/ml. 
Appearance of Paracetamol solid dispersion 
Pure form of PCM having the crystalline nature where as 
the physical mixture of PEG:PCM having the off sticky 
appearance and the prepared solid dispersion of 
formulation shows the solid sticky lumps at temperature 37 
oC but at above this temperature it starts melting and 
physical property on the basis of integrity of dispersions it 
starts changing as the temperature and time progress. 
Table 3: Appearance of solid dispersion formulation 
Formulation Code Method Nature of formulation 
RD - White crystalline powder 
F1* Trituration Off sticky texture 
F1 Melting Solid sticky lumps 
F2 Melting Solid sticky lumps 
F3 Melting Solid sticky lumps 
F4 Melting Solid sticky lumps 
Drug content analysis 
Preparation equivalent to 100 mg was accurately weighed 
and transferred to 100 ml volumetric flask and mixed in 
100 ml phosphate buffer having pH 5.8., suitable aliquots 
were withdrawn and diluted to appropriate dilution and 
drug content was established using calibration curve of 
PCM at max 243 nm. The drug content was found to be 
between 93.78% to 99.04% as compared with respect to 
the standard one. This explains that the drug is properly 
dispersed in the carrier phase which shows the higher 
significance value. 
In vitro release profile study   
The formulation of solid dispersions with carrier like PEG 
4000 was formulated and proves a better release profile at 
pH 5.8 phosphate buffer. However it was also 
experimented and observed that the prepared solid 
dispersions with these carriers shows a better release 
characteristics as compared with the raw drug (RD) and 
physical mixture (F1*). Formulation F4 reveals the faster 
dissolution rate as compared to the other formulations 
because in this the ratio of carrier is high and this leads to 
the faster release of this formulation. From the release 
graph which was plotted against the time also shows there 
is slowly release of the drug from this carrier because at 
the earlier of the few minutes there is not enough time to 
get between the carrier and media to increase the 
wettability of the carriers and as the time progresses the 
wetability increases and this finally leads to the better 
release of the drug. 
These observations however indicates that the better and 
enhanced dissolution of the dispersions is due to the 
increased wettability of the drug and carrier, particle size 
reduction in the case of during preparation and phase 
transformation between these two.   
 
 
Figure 2: Release profiles of various formulations at 
pH 5.8 phosphate buffer 
Release kinetics of the solid dispersions 
The in vitro release kinetics of various formulations was 
analyzed by fitting the various models as mentioned in the 
above table. While establishing the release kinetics with 
various formulations it was found that the formulation RD, 
F1*, F1, F2 and F4 fallows a zero order kinetics because in 
this calculated r2 value were higher and it explains that the 
release rate is independent of the concentration of the drug. 
While establishing connection to the release kinetics in F3 
it was observed that the r2 value in Higuchi role model was 
higher and it reveals that the solid drug is dispersed in a 
soluble matrix and the rate of drug release is related to the 
rate of drug diffusion. The n values from drug release 
experiment ranged from 0.58-0.78, indicated anomalous 
non-Fickian transport, which suggest that mechanism and 
kinetics of drug release were dependent on the solubility of 
solid dispersion formulation in dissolution medium. 
Table 4: Release kinetics of the solid dispersion 
Formulation Code r
2 
Value  
n value Zero order First order Higuchi  Korsmeyer-Peppa’s  
RD 0.9920 0.7302 0.9106 0.9227 0.76 
F1* 0.9991 0.6758 0.8659 0.5431 0.60 
F1 0.9791 0.6797 0.9231 0.9777 0.60 
F2 0.9957 0.7915 0.9116 0.9897 0.77 
F3 0.9382 0.5548 0.9839 0.9974 0.58 
F4 0.9457 0.7893 0.8902 0.9563 0.78 
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Stability studies of the solid dispersions 
In the present contrast of study we have done some extent 
of stability study as per the established guidelines. During 
this the prepared dispersions were sealed in hermitically 
sealed containers (ampoules) of different formulations. 
After storage at room conditions for six months the 
prepared solid dispersions were characterized for physical 
appearance, solubility studies, drug content analysis and 
dissolution profile studies.  
It was found that there is no any much more changes occur 
to the solid dispersions formulations with using PEG 4000 
as a carrier. However there is much more study needed 
during the stability studies of dispersion by following the 
ICH guidelines. 
CONCLUSION 
In this present study we have prepared the solid dispersion 
of Paracetamol using PEG 4000 as a carrier. Due to 
hydrophilic nature of this carrier molecule this supports the 
creation of hydrophilic environment to the dispersion solid 
and increases the wettability of the Paracetamol which 
leads to increase in the dissolution rate. In this study we 
observe that by increasing the concentration of carrier the 
dissolution and solubility profile also increases. This 
carrier also proves the better in terms of stability. We 
propose that the prepared solid dispersion using PEG 4000 
was able to improve the solubility and dissolution profile 
of poorly water soluble drug without changing in its 
integrity.  
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